{"name":"Piramal Pharma","slug":"piramal-pharma","ticker":"PPLPHARMA.NS","exchange":"NSE","domain":"piramal.com","description":"Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene, as well as adult incontinence. The company was incorporated in 2020 and is based in Mumbai, India.","hq":"Mumbai, India","founded":0,"employees":"","ceo":"","sector":"CDMO / Complex Generics / Consumer Healthcare","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":174.56,"stockChange":-2.83,"stockChangePercent":-1.6,"marketCap":"$2.4B","metrics":{"revenue":926245723.7772288,"revenueGrowth":-0.1,"grossMargin":63.5,"rdSpend":0,"netIncome":-34039665.459113605,"cash":141553791.30379522,"dividendYield":8,"peRatio":40.3,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"yahoo_finance","revenue":926245695.705,"revenuePeriod":"2026-03-31","revenueHistory":[{"period":"2026-03-31","value":926245695.705},{"period":"2025-03-31","value":955706914.9925001},{"period":"2024-03-31","value":846595968.2537501},{"period":"2023-03-31","value":734432375.5037501}],"grossProfit":588027556.3525001,"grossProfitHistory":[{"period":"2026-03-31","value":588027556.3525001},{"period":"2025-03-31","value":618208335.3737501},{"period":"2024-03-31","value":506266145.61875004},{"period":"2023-03-31","value":421107452.13625}],"rdSpend":10143807.97375,"rdSpendHistory":[{"period":"2025-03-31","value":10143807.97375},{"period":"2024-03-31","value":10513509.20125},{"period":"2023-03-31","value":9019038.985000001},{"period":"2022-03-31","value":13403236.027500002}],"sgaSpend":63231442.1475,"operatingIncome":9438869.1925,"operatingIncomeHistory":[{"period":"2026-03-31","value":9438869.1925},{"period":"2025-03-31","value":65636588.83375},{"period":"2024-03-31","value":48252276.31125},{"period":"2023-03-31","value":-5009764.938750001}],"netIncome":-34039666.127500005,"netIncomeHistory":[{"period":"2026-03-31","value":-34039666.127500005},{"period":"2025-03-31","value":9517195.72375},{"period":"2024-03-31","value":1861038.3825},{"period":"2023-03-31","value":-19473020.0225}],"eps":-2.46,"epsHistory":[{"period":"2026-03-31","value":-2.46},{"period":"2025-03-31","value":0.68},{"period":"2024-03-31","value":0.14},{"period":"2023-03-31","value":-1.54}],"cash":125309917.75500001,"cashHistory":[{"period":"2026-03-31","value":125309917.75500001},{"period":"2025-03-31","value":38534564.667500004},{"period":"2024-03-31","value":37264630.5075},{"period":"2023-03-31","value":20426514.99625}],"totalAssets":1876185689.2900002,"totalLiabilities":1023719408.6075001,"totalDebt":592627934.62125,"equity":852466280.6825,"operatingCashflow":172588856.37125,"operatingCashflowHistory":[{"period":"2026-03-31","value":172588856.37125},{"period":"2025-03-31","value":93187685.11250001},{"period":"2024-03-31","value":104909511.6025},{"period":"2023-03-31","value":50535233.60875}],"capex":-92949572.45750001,"capexHistory":[{"period":"2026-03-31","value":-92949572.45750001},{"period":"2025-03-31","value":-69384774.44250001},{"period":"2024-03-31","value":-74362164.415},{"period":"2023-03-31","value":-100754028.03125}],"freeCashflow":79639283.91375001,"dividendsPaid":-1937276.20625,"buybacks":null,"employees":0,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":null,"ebit":13157812.89625,"ebitda":35964410.088750005,"period":"2026-03-31","revenue":287382131.86375004,"epsBasic":-0.07,"netIncome":-921120.0075000001,"rdExpense":null,"epsDiluted":-0.07,"grossProfit":177132839.53750002,"operatingIncome":25286937.348750003},{"sga":null,"ebit":-482491.43250000005,"ebitda":21735090.245,"period":"2025-12-31","revenue":223478125.90125,"epsBasic":-1.03,"netIncome":-14223053.721250001,"rdExpense":null,"epsDiluted":-1.03,"grossProfit":141359546.185,"operatingIncome":-1776445.72875},{"sga":null,"ebit":744624.22375,"ebitda":21347635.00375,"period":"2025-06-30","revenue":201947728.99125,"epsBasic":-0.62,"netIncome":-8532370.137500001,"rdExpense":null,"epsDiluted":-0.62,"grossProfit":129464356.97250001,"operatingIncome":-9459756.2675},{"sga":null,"ebit":39317829.980000004,"ebitda":64670561.615,"period":"2025-03-31","revenue":287622333.22625,"epsBasic":1.16,"netIncome":16030830.062500002,"rdExpense":null,"epsDiluted":1.16,"grossProfit":187888638.80875,"operatingIncome":33234469.386250004},{"sga":null,"ebit":17765501.64125,"ebitda":38319427.795,"period":"2024-12-31","revenue":230198542.28250003,"epsBasic":0.03,"netIncome":384322.18000000005,"rdExpense":null,"epsDiluted":0.03,"grossProfit":146041384.04625002,"operatingIncome":14718077.398750002}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":174.56,"previousClose":177.39,"fiftyTwoWeekHigh":226,"fiftyTwoWeekLow":132.3,"fiftyTwoWeekRange":"132.3 - 226.0","fiftyDayAverage":151.65,"twoHundredDayAverage":174.49,"beta":0.37,"enterpriseValue":2748084222.4349184,"forwardPE":40.3,"priceToBook":2.86,"priceToSales":2.61,"enterpriseToRevenue":2.97,"enterpriseToEbitda":30.08,"pegRatio":0,"ebitda":91364239.4546816,"ebitdaMargin":9.9,"freeCashflow":70466464.9251904,"operatingCashflow":172588854.0318976,"totalDebt":592627913.5670785,"debtToEquity":69.5,"currentRatio":1.51,"returnOnAssets":0.3,"returnOnEquity":-4,"analystRating":"1.5 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":11,"targetMeanPrice":203,"targetHighPrice":255,"targetLowPrice":170,"dividendRate":0.14,"payoutRatio":0.15,"fiveYearAvgDividendYield":0,"exDividendDate":1752624000,"insiderHeldPercent":54.5,"institutionHeldPercent":20.7,"sharesOutstanding":1324744010,"floatShares":580104000,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":-2.47,"epsForward":4.33,"revenuePerShare":66.94,"bookValue":61.03,"officers":[{"age":45,"name":"Ms. Nandini Ajay Piramal","title":"Executive Chairperson"},{"age":52,"name":"Mr. Vivek  Valsaraj","title":"CFO & Executive Director"},{"age":47,"name":"Mr. Peter Daniel DeYoung","title":"CEO of Piramal Global Pharma & Director"},{"age":61,"name":"Vinay  Agarwal","title":"Senior Vice President of Operations"},{"age":51,"name":"Mr. Viral  Gandhi","title":"President & Group CIO of Piramal Group"},{"age":null,"name":"Mr. Gagan  Borana","title":"Head of Investor Relations & Sustainability"},{"age":null,"name":"Mr. Sandeep K. Rathod","title":"General Counsel"},{"age":null,"name":"Mr. Maneesh  Sharma","title":"Company Secretary & Compliance Officer"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.piramalpharma.com","phone":"91 22 3802 3000"}}